61 related articles for article (PubMed ID: 26297554)
1. Identification of mutations in Colombian patients affected with Fabry disease.
Uribe A; Mateus HE; Prieto JC; Palacios MF; Ospina SY; Pasqualim G; da Silveira Matte U; Giugliani R
Gene; 2015 Dec; 574(2):325-9. PubMed ID: 26297554
[TBL] [Abstract][Full Text] [Related]
2.
Li P; Xi Y; Zhang Y; Samad A; Lan W; Wu Y; Zhao J; Chen G; Wu C; Xiong Q
Cells; 2024 Mar; 13(5):. PubMed ID: 38474401
[TBL] [Abstract][Full Text] [Related]
3. A Classical Phenotype of Fabry Disease with Novel Mutation Found by Kidney Biopsy, A Case Report.
Matsumoto K; Ishii M; Mizuta M; Nakamura M; Matsumoto R; Ikeda Y; Yamasaki M; Fukuda M; Miyazono M
Iran J Kidney Dis; 2023 Nov; 17(6):348-350. PubMed ID: 38043112
[TBL] [Abstract][Full Text] [Related]
4. Diagnosing Fabry nephropathy: the challenge of multiple kidney disease.
Esposito P; Caputo C; Repetto M; Somaschini A; Pietro B; Colomba P; Zizzo C; Parodi A; Zanetti V; Canepa M; Eustachi V; Sanguineri F; Mandich P; Viazzi F
BMC Nephrol; 2023 Nov; 24(1):344. PubMed ID: 37990184
[TBL] [Abstract][Full Text] [Related]
5. Cornea Verticillata in classical Fabry disease, first from Sri Lanka: a case report.
Hewavitharana H; Jasinge E; Abeysekera H; Wanigasinghe J
BMC Pediatr; 2020 Jul; 20(1):338. PubMed ID: 32641113
[TBL] [Abstract][Full Text] [Related]
6. Morbus Fabry and Parkinson's Disease-More Evidence for a Possible Genetic Link.
Müller S; Kassubek J; Hold ST; Kasper DC; Mayer B; Müller K; Freischmidt A; Siebert R; Braak H; Ludolph AC; Del Tredici K
Mov Disord; 2024 Feb; 39(2):449-451. PubMed ID: 38226450
[No Abstract] [Full Text] [Related]
7. Genetic variants associated with gastrointestinal symptoms in Fabry disease.
Di Martino MT; Scionti F; Sestito S; Nicoletti A; Arbitrio M; Hiram Guzzi P; Talarico V; Altomare F; Sanseviero MT; Agapito G; Pisani A; Riccio E; Borrelli O; Concolino D; Pensabene L
Oncotarget; 2016 Dec; 7(52):85895-85904. PubMed ID: 27825144
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Induced Pluripotent Stem Cells (iPSCs) Disease Model of Fabry Disease Caused by a Novel GLA Mutation.
Gao L; Lu Z; Zhang Y; Liu L; Sun J; Fu H; Mao J; Hu L
QJM; 2024 Mar; ():. PubMed ID: 38429952
[TBL] [Abstract][Full Text] [Related]
9. Functional and Clinical Consequences of Novel α-Galactosidase A Mutations in Fabry Disease.
Lukas J; Scalia S; Eichler S; Pockrandt AM; Dehn N; Cozma C; Giese AK; Rolfs A
Hum Mutat; 2016 Jan; 37(1):43-51. PubMed ID: 26415523
[TBL] [Abstract][Full Text] [Related]
10. Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease.
Goker-Alpan O; Gambello MJ; Maegawa GH; Nedd KJ; Gruskin DJ; Blankstein L; Weinreb NJ
JIMD Rep; 2016; 25():95-106. PubMed ID: 26303609
[TBL] [Abstract][Full Text] [Related]
11. GLA variation p.E66Q identified as the genetic etiology of Fabry disease using exome sequencing.
Peng H; Xu X; Zhang L; Zhang X; Peng H; Zheng Y; Luo S; Guo H; Xia K; Li J; Yao H; Hu Z
Gene; 2016 Jan; 575(2 Pt 1):363-7. PubMed ID: 26456105
[TBL] [Abstract][Full Text] [Related]
12. De novo Diagnosis of Fabry Disease among Italian Adults with Acute Ischemic Stroke or Transient Ischemic Attack.
Romani I; Borsini W; Nencini P; Morrone A; Ferri L; Frusconi S; Donadio VA; Liguori R; Donati MA; Falconi S; Pracucci G; Inzitari D
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2588-95. PubMed ID: 26298600
[TBL] [Abstract][Full Text] [Related]
13. Newborn Screening for Lysosomal Storage Disorders: Views of Genetic Healthcare Providers.
Lisi EC; McCandless SE
J Genet Couns; 2016 Apr; 25(2):373-84. PubMed ID: 26315880
[TBL] [Abstract][Full Text] [Related]
14. [Fabry Disease: Pathogenesis, Clinical Symptoms, and Treatment with Enzyme Replacement Therapy].
Sawai S
Brain Nerve; 2015 Sep; 67(9):1099-108. PubMed ID: 26329150
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical investigation of male patients exhibiting membranous cytoplasmic bodies in biopsied kidney tissues; a pitfall in diagnosis of Fabry disease.
Sakuraba H; Tsukimura T; Tanaka T; Togawa T; Takahashi N; Mikami D; Wakai S; Akai Y
J Nephropathol; 2015 Jul; 4(3):91-6. PubMed ID: 26312237
[TBL] [Abstract][Full Text] [Related]
16. Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease.
Pisani A; Daniele A; Di Domenico C; Nigro E; Salvatore F; Riccio E
BMC Res Notes; 2015 Nov; 8():711. PubMed ID: 26602202
[TBL] [Abstract][Full Text] [Related]
17. Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype-phenotype expression.
Paliouras C; Aperis G; Lamprianou F; Ntetskas G; Roufas K; Alivanis P
Nefrologia; 2015; 35(6):578-81. PubMed ID: 26384850
[TBL] [Abstract][Full Text] [Related]
18. Eight-Year Follow-Up of Neuropsychiatric Symptoms and Brain Structural Changes in Fabry Disease.
Lelieveld IM; Böttcher A; Hennermann JB; Beck M; Fellgiebel A
PLoS One; 2015; 10(9):e0137603. PubMed ID: 26340726
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal involvement in Fabry disease. So important, yet often neglected.
Politei J; Thurberg BL; Wallace E; Warnock D; Serebrinsky G; Durand C; Schenone AB
Clin Genet; 2016 Jan; 89(1):5-9. PubMed ID: 26333625
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke.
Kilarski LL; Rutten-Jacobs LC; Bevan S; Baker R; Hassan A; Hughes DA; Markus HS;
PLoS One; 2015; 10(8):e0136352. PubMed ID: 26305465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
